Petauri Acquires Artia Solutions to Expand Medicaid Market Access Capabilities

Petauri Acquires Formulary Insights

November 13, 2024

Healthcare Services

Petauri, a PE‑backed pharmaceutical services platform based in Nashville, has acquired Formulary Insights and merged the business into Petauri Advisors to expand its market access research and strategy capabilities. The acquisition broadens Petauri’s payer and market access offerings for biopharmaceutical clients and is supported by Oak Hill Capital, which is backing the platform with a multi‑hundred million dollar commitment.

Petauri Health (Oak Hill) Acquires The Kinetix Group

June 13, 2023

Healthcare Services

Petauri Health, a pharmaceutical commercialization platform formed by Oak Hill Capital, has acquired The Kinetix Group (TKG), a New York–based market access, access marketing, and medical affairs agency. The Kinetix founders will remain in leadership roles as TKG becomes the inaugural add-on to the Petauri platform, expanding the platform's market access, medical affairs, and real-world evidence capabilities.

Petauri Acquires FORCE Communications

February 14, 2024

Healthcare Services

Petauri, a pharmaceutical services platform backed by Oak Hill Capital, has acquired FORCE Communications and its three independent agencies — DRIVE, MOMENTUM, and PROPEL. The add-on expands Petauri's scientific communications and medical education capabilities as the platform continues to build scale in medical affairs, market access, patient services, and data and analytics.

Petauri Acquires Bluprint Oncology, Cogency, Verascity and Blendworks from Brightly Network

August 14, 2024

Healthcare Services

Petauri, the Oak Hill Capital–backed pharmaceutical services platform, acquired four U.S.-based medical communications agencies — Bluprint Oncology, Cogency, Verascity, and Blendworks — from the Brightly Network. The additions expand Petauri Advance's oncology, hematology and rare-disease communications capabilities and increase the platform's depth in medical and commercial strategy, engagement, and education.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

Elevate Patient Financial Solutions Acquires Centauri Health Solutions' Health Systems Services Division

February 17, 2026

Healthcare Services

Elevate Patient Financial Solutions (ElevatePFS) has completed a carve-out acquisition of the Health Systems Services division of Centauri Health Solutions. The deal — terms not disclosed — adds Centauri's Medicaid and disability eligibility/enrollment, out-of-state Medicaid billing, and other complex revenue cycle capabilities to ElevatePFS's revenue cycle management platform to better serve health system clients.